1. „Biotech 94: Long-term value/Short-term hurdles” (1993) Ernst & Young’s eighth annual report on the biotechnology industry.
2. „Comparative quarterly financial data for U. S. public biotech companies” (1996) Biotechnol News, Vol. 16, Heft 24, pp. 4–7.
3. “Biotech 95: Reform, restructure, renewal” (1994) Ernst & Young’s ninth annual report on the biotechnology industry.
4. “Biotech 94: Long-term value/Short-term hurdles” (1993) Ernst & Young’s eigth annual report on the biotechnology industry.
5. “Biotech 93: Accelerating/Commercialization” (1992) Ernst & Young’s seventh annual report on the biotechnology industry.